Cited by 6Cancer-related molecular mechanisms researchMicroRNA in disease regulationHippo pathway signaling and YAP/TAZ

Critical analysis of the hypothesized SNHG1/miR-195-5p/YAP1 axis

Open access
Zielske, Steven P., Cackowski, Frank C.·2023·Functional & Integrative Genomics

Abstract

How lncRNAs such as SNHG1 are integrated into cellular pathways to regulate, or be a regulatory component of, cellular processes is a question yet to be completely answered.A potential mechanism by which SNHG1 may exert its effect is through the so-called sponge effect.In this mechanism, SNHG1 (or other lncRNAs) is thought to bind miRNAs as a molecular sponge in a sequence-specific manner and inhibit their ability to bind and inhibit translation of a specific mRNA.The recent paper by Cheng et al. (Cheng et al. 2022) makes just these connections, in this case, between SNHG1, miRNA-195-5p, and the Hippo pathway gene, YAP1.In their proposed model, miRNA-195-5p binds to, and causes degradation of, YAP1 mRNA.MiRNA-195-5p is in turn modulated through the sponging activity of SNHG1.These interactions theoretically occur through a region of 7 nucleotide complementarity.Thus, YAP1 target protein expression can be modulated through a complex interplay involving the degree of SNHG1 and miR-195-5p expression.High SNHG1 should lead to greater sponging of miR-195-5p, and result in high YAP1 mRNA and protein levels, and conversely, low SNHG1 should lead to less sponging of miR-195-5p, and therefore low YAP1 mRNA and protein levels.However, we would like to call attention to some aspects of the published study which are common in the field overall and to offer a counterpoint to the conclusions drawn.In the human genome, there are possibly 183,000 occurrences of the 7 nucleotide sequence being suggested to confer specificity in the binding of SNHG1 to miR-195-5p and, subsequently, YAP1 (calculated as the 3 billion bp human genome divided by the frequency of random appearance of the given 7 nt sequence -4 7 ).Within protein-coding regions, which are estimated to be 1.5% of the genome, there may be 2746 (4.5 × 10 7 /4 7 ) occurrences of this sequence.Indeed, miRNA target prediction websites (miRDB, miRDB.organd

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10142-022-00930-z

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zielske, S. P., & Cackowski, F. C.
Affiliations
Wayne State University (US)
Corresponding author
Cackowski, Frank C.
Venue
Functional & Integrative Genomics
Published
2022-12-17
Volume
23
Issue
1
Pages
2-2
ISSN
  • 1438-793X (ISSN-L)
  • 1438-7948
OpenAlex
W4312066467
Cited by
6
References
8
Citations by year
2024: 1 · 2023: 5
Type
journal article
Language
en
Open access
Locations
  • Functional & Integrative Genomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (P50CA186786)
  • DOD Prostate Cancer Research Program (W81XWH2010394)
  • Barbara Ann Karmanos Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Keywords
SNHG1, miR-195-5p, YAP, long non-coding RNA, Hippo signaling pathway, miRNA target prediction
MeSH terms
Gene Expression Regulation, Neoplastic, MicroRNAs, Cell Line, Tumor, Cell Proliferation, RNA, Long Noncoding

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review